References
- Blalock J. E. The immune system as a sensory organ. Journal of Immunology 1984; 132: 1067–1070
- Berczi I., Nagy E. Effects of hypophysectomy on immune function. Psychoneuroimmunology, R. Ader, D. L. Felten, N. Cohen. Academic Press., San Diego 1991; 339–375
- Carr D. J. J., Radulescu R. T., Blalock J. E. Phentolamine augmentation of total and antigen-specific immunoglobulin production by splenic and Peyer's patch lymphocytes from mice orally immunized with SRBCs. Progress in Neuroendocrinimmunology 1992a; 3: 125–135
- Carr D. J. J., Radulescu R. T., DeCosta B. R., Rice K. C., Blalock J. E. Differential effect of opioids on immunoglobulin production by lymphocytes isolated from Peyer's patches and spleen. Life Sciences 1990; 47: 1059–1069
- Carr D. J. J., Woolley T. W., Blalock J. E. Phentolamine but not propranolol blocks the immunopotentiating effect of cold stress on antigen-specific IgM production in mice orally immunized with sheep red blood cells. Brain, Behavior and Immnunity 1992b; 6: 50–63
- Cross R. J., Campbell J. L., Roszman T. L. Potentiation of antibody responsiveness after the transplantation of syngeneic pituitary gland. Journal of Neuroimmunology 1989; 25: 29–45
- Felten S. Y., Felten D. L., Bellinger D. L., Carlson S. L., Akerman K. D., Madden K. S., Olschowka J. A., Livnat S. Noradrenergic sympathetic innervation of lymphoid organs. Chemical immunology, J. E. Blalock, 1988; 43: 14–67
- Felten D. L., Felten S. Y., Carlson S. L., Olschowka J. A., Linvat S. Noradrenergic and peptidergic innervation of lymphoid tissue. Journal of Immunology 1985; 135: 755s–765s
- Gordon J., Katira A., Strain A. J., Gillis S. Inhibition of interleukin-4-promoted CD23 production in human B lymphocytes by transforming growth factor-β interferons or anti-CD19 antibody is overridden on engaging CD40. European Journal of Immunology 1991; 21: 1917–1922
- Ishizaka S., Yoshikawa M., Tsujii T. Immunoregulatory effects of transforming growth factor-β in a prolonged period of culture. Cellular Immunology 1992; 139: 239–247
- Mattingly J. A., Waksman B. H. Immunologic suppression after oral administration of antigen. Journal of Immunulogy 1978; 121: 1878–1883
- Miller A., Lider O., Roberts A. B., Sporn M. B., Weiner H. L. Suppressor T cells generated by oral tolerization to myelin basic protein suppress both in vitro and in vivo immune responses by the release of transforming growth factor beta after antigen specific triggering. Proceedings of the National Academy of Sciences USA 1992; 89: 421–425
- Ottaway C. A. In vitro alteration of receptors for vasoactive intestinal peptide changes the in vivo localization of mouse T cells. Journal of Experimental Medicine 1984; 160: 1054–1069
- Paul W. E., Ohara J. B-cell stimulating factor-1/interleukin-4. Annual Reviews of Immunology 1987; 5: 429–459
- Spangelo B. L., Hall N. R. S., Ross P. C., Goldstein A. L. Stimulation of in vivo antibody production and concanavalin A-induced mouse spleen cell mitogenesis by prolactin. Immunopharmacology 1987; 14: 11–20
- Stanisz A. M., Befus D., Bienenstock J. Differential effects of vasoactive intestinal peptide, substance P, and somatostatin on immunoglobulin synthesis and proliferation by lymphocytes from Peyer's patches, mesenteric lymph nodes, and spleen. Journal of Immunology 1986; 136: 152–156
- Tagliabue A., Luini W., Soldateschi D., Boraschi D. Natural killer activity of gut mucosal lymphoid cells in mice. European Journal of Immunology 1981; 11: 919–922